Surgical endoscopy
-
Randomized Controlled Trial Multicenter Study
Drain after elective laparoscopic cholecystectomy. A randomized multicentre controlled trial.
Routine drainage after laparoscopic cholecystectomy is still debatable. The present study was designed to assess the role of drains in laparoscopic cholecystectomy performed for nonacutely inflamed gallbladder. ⋯ The present study was unable to prove that the drain was useful in elective, uncomplicated LC.
-
Multicenter Study Controlled Clinical Trial
The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
Sphincter augmentation with the LINX® Reflux Management System is a surgical option for patients with chronic gastroesophageal disease (GERD) and an inadequate response to proton pump inhibitors (PPIs). Clinical experience with sphincter augmentation is now available out to 4 years. ⋯ Sphincter augmentation with the LINX Reflux Management System provided long-term clinical benefits with no safety issues, as demonstrated by reduced esophageal acid exposure, improved GERD-related quality of life, and cessation of dependence on PPIs, with minimal side effects and no safety issues. Patients with inadequate symptom control with acid suppression therapy may benefit from treatment with sphincter augmentation.